FDA expands approval of Roche's bleeding disorder drug
Roche said on Thursday U.S. regulators approved its hemophilia A drug Hemlibra, expanding its use in nearly all patients, as the Swiss drugmaker pushes deeper into diseases beyond cancer to replace revenue from older, patent-expired drugs. (Source: Reuters: Health)
Source: Reuters: Health - October 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Flu drug speeds relief from symptoms in at-risk patients: Roche
Influenza drug baloxavir marboxil significantly sped time to relief for patients highly vulnerable to serious complications, a late-stage clinical trial has shown, Swiss drugmaker Roche said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - October 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

With Hemlibra, Roche seeks to break into tight hemophilia circle
Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder. (Source: Reuters: Health)
Source: Reuters: Health - October 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis strikes deal with Chinese firm to make Kymriah
Novartis has enlisted Chinese manufacturer Cellular Biomedicine (CBMG) to make its $475,000 gene-modifying cancer treatment Kymriah as the Swiss drugmaker intends to win approval for the therapy in the world's most populous country. (Source: Reuters: Health)
Source: Reuters: Health - September 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis to cut more than 2,000 jobs in Switzerland, Britain
The drugmaker will cut down the workforce at four Switzerland plants and one UK-based facility. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 25, 2018 Category: Pharmaceuticals Source Type: news

Roche's Tecentriq, trailing rival drugs, lifts lung cancer survival
A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, according to a study, aiding the Swiss group's bid to win approval in a niche disease area before rivals that now dominate the immunotherapy market. (Source: Reuters: Health)
Source: Reuters: Health - September 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche's Tecentriq adds two months to lung cancer patients' lives: study
A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, potentially aiding the Swiss company's bid to win approval in a niche disease area before rivals that now dominate the immunotherapy market. (Source: Reuters: Health)
Source: Reuters: Health - September 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis slashes jobs in UK and Switzerland
Thousands of positions to go as part of sweeping global cost cuts (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 25, 2018 Category: Pharmaceuticals Source Type: news

With new blood test, Roche dives deeper into personal cancer care
Swiss drugmaker Roche upped its bet on personalized cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mutations from solid tumors from a patient's blood. (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Roche deepens push into personalized cancer care with new test
Swiss drugmaker Roche upped its bet on personalized cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common cancer gene mutations from a patient's blood. (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Swiss vote on bids to improve food quality, protect farmers
Swiss voters are deciding on two separate proposals aimed to ensure that food from both domestic and foreign farmers and producers is healthier, more environmentally sound and animal-friendly, and protect Swiss farmers more too (Source: ABC News: Health)
Source: ABC News: Health - September 23, 2018 Category: Consumer Health News Tags: Health Source Type: news

Sexual and reproductive healthcare for women asylum seekers in Switzerland: a multi-method evaluation - Cignacco E, Zu Sayn-Wittgenstein F, S énac C, Hurni A, Wyssmüller D, Grand-Guillaume-Perrenoud JA, Berger A.
BACKGROUND: Forced migration significantly endangers health. Women face numerous health risks, including sexual violence, lack of contraception, sexually transmitted disease, and adverse perinatal outcomes. Therefore, sexual and reproductive healthcare is ... (Source: SafetyLit)
Source: SafetyLit - September 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Sexual sadism among sex offenders in Switzerland - Gon çalves LC, Rossegger A, Gerth J, Singh JP, Endrass J.
This study cross validated the SeSaS in Switzerland using a sample of 179 male sex offenders. Spe... (Source: SafetyLit)
Source: SafetyLit - September 21, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

API expands health data into risk scores, but are consumers ready for it?
Matt Park, the general manager of the Swiss-based Dacadoo Americas, explains how the company ’s health scoring app works and their bet consumers also want to calculate their real time health risks with a new component of the open API. (Source: mobihealthnews)
Source: mobihealthnews - September 21, 2018 Category: Information Technology Source Type: news

Cardiovalve launches pivotal TMVR trials
Israel cardiovascular device developer Cardiovalve said yesterday it launched both the Ahead US and Ahead EU multicenter studies of its Cardiovalve transfemoral mitral valve replacement system. The company’s flagship Cardiovalve system is a novel mitral valve designed for either transferal or transeptal use and is intended to replace the mitral valve through a minimally invasive procedure. Cardiovalve touted that the device features a short profile for minimal protrusion to the left ventricle and minimized interference in cardiac blood flow. Cardiovalve said that will begin enrollment in the Ahead US trial early in t...
Source: Mass Device - September 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves cardiovalve Source Type: news

Nestlé plans to sell or spin off skin health unit
Decision likely to fuel speculation over Swiss group’s L’Oréal stake (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 20, 2018 Category: Pharmaceuticals Source Type: news

Oculis Elects Anthony Rosenberg and David A. Weber - Veterans of the Global Pharmaceutical and Eye-care Industries - to its Board of Directors
LAUSANNE, Switzerland, September 19, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis, a clinical-stage biotechnology company developing next-generation topical treatments for acute and chronic back- and front-of-the-eye diseases, announces the ap... Biopharmaceuticals, Ophthalmology, Personnel Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2018 Category: Pharmaceuticals Source Type: news

Biotech co. hosts career fair at new Pearland facility, aims to hire 200 by end of 2019
Switzerland-based biotech giant Lonza Group Ltd. is moving forward with plans to double its workforce at its recently opened Pearland facility, billed as the largest dedicated cell and gene therapy manufacturing facility in the world. The 300,000-square-foot facility officially opened in April with 170 employees. Ricardo Jimenez, site director at Lonza Houston Inc., told the Houston Business Journal at the time that the space could support more than 400 workers.  Now, the company is holding its… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 18, 2018 Category: Biotechnology Authors: Olivia Pulsinelli Source Type: news

Biotech co. hosts career fair at new Pearland facility, aims to hire 200 by end of 2019
Switzerland-based biotech giant Lonza Group Ltd. is moving forward with plans to double its workforce at its recently opened Pearland facility, billed as the largest dedicated cell and gene therapy manufacturing facility in the world. The 300,000-square-foot facility officially opened in April with 170 employees. Ricardo Jimenez, site director at Lonza Houston Inc., told the Houston Business Journal at the time that the space could support more than 400 workers.  Now, the company is holding its… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 18, 2018 Category: American Health Authors: Olivia Pulsinelli Source Type: news

Luciole Medical raised $5.5 million for blood oxygen probe
Swiss startup Luciole Medical announced today that it has closed a $5.5 million (CHF 5.3 million) Series A  financing round to begin commercializing its minimally-invasive monitoring probe to measure blood oxygen levels in the brains of patients in intensive care units. New investor SVC Ltd. (a subsidiary of Credit Suisse), led the round with Blue Ocean Ventures, Investiere and B-to-V as co-investors with significant support from existing shareholder Zürcher Kantonalbank. The company will also use some of the money to continue developing a non-invasive patch designed to measure oxygen saturation and blood flow in...
Source: Mass Device - September 17, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Funding Roundup Patient Monitoring b-to-v blueoceanventures CreditSuisse investiere luciolemedical svcltd. Source Type: news

Fertile Females Smell Better to Men
Researchers in Switzerland determined that women who are the "fittest" for reproduction have a distinctive scent that makes them particularly appealing to men. (Source: WebMD Health)
Source: WebMD Health - September 17, 2018 Category: Consumer Health News Source Type: news

Scent of a Woman: Fertile Females Smell Better to Men
MONDAY, Sept. 17, 2018 -- New research suggests there is no perfume a man loves more than the scent of a fertile woman. Researchers in Switzerland determined that women who are the " fittest " for reproduction have a distinctive scent that makes them... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 17, 2018 Category: General Medicine Source Type: news

Europe ’ s Triumphs and Troubles Are Written in Swiss Ice
Pollen frozen in ice in the Alps traces Europe ’ s calamities, since the time Macbeth ruled Scotland. (Source: NYT Health)
Source: NYT Health - September 17, 2018 Category: Consumer Health News Authors: HANNAH HOAG Tags: Ice Glaciers Pollen Agriculture and Farming Alps Mountains Source Type: news

Invitation to Roche's 9 Months Sales 2018 Audio Webcast and Conference Call
Roche will publish its Sales Results for the 3rd Quarter of 2018 prior to the opening of the Swiss Stock Exchange on Wednesday, October 17th, 2018. (Source: Roche Investor Update)
Source: Roche Investor Update - September 17, 2018 Category: Pharmaceuticals Source Type: news

Roche Boss Says Brexit and Curbs on Drug Use Pose Threat to UK Science Roche Boss Says Brexit and Curbs on Drug Use Pose Threat to UK Science
Uncertainty over drug regulation and a reluctance by Britain's health service to use certain pricey modern medicines pose a threat to the country's respected life sciences sector, the head Swiss drugmaker Roche said on Thursday.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 16, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Big five personality traits and the general factor of personality as moderators of stress and coping reactions following an emergency alarm on a Swiss university campus - Hengartner MP, Linden D, Bohleber L, Wyl A.
We conducted an online survey including 306 participants aged 18-64 years to assess the general factor of personality (GFP) and Big Five personality traits in relation to individual stress and coping reactions following a shooting emergency alarm at a Swis... (Source: SafetyLit)
Source: SafetyLit - September 15, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Russians Allegedly Targeted Lab Studying Chemical Weapons
Russian agents were allegedly planning to hack into a Swiss laboratory that was analyzing nerve agents used in March against a former Russian spy and his daughter.(Image credit: FABRICE COFFRINI/AFP/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - September 14, 2018 Category: Consumer Health News Authors: Geoff Brumfiel Source Type: news

Are fungi the secret to a sweet sounding violin? – Science Weekly podcast
From making violins sound beautiful, to beer and bread, to creating life-saving medicine, fungi have an array of very useful attributes. This week, a report demonstrates just how little we know about this kingdom of life and what we are set to gain if we tap into fungi as a resource.Hannah Devlin investigates.Join the discussion onFacebook andTwitterThe more mycologists study fungi, the more they ’re beginning to realise what an intriguing kingdom of life it is. Life-saving drugs like statins, penicillin and the immunosuppressants used in organ donation are all derived from fungi, as is the yeast used in bread and be...
Source: Guardian Unlimited Science - September 14, 2018 Category: Science Authors: Presented by Hannah Devlin and produced by Graihagh Jackson Tags: Science Environment Fungi Music Source Type: news

Roche boss says Brexit and curbs on drug use pose threat to UK science
Uncertainty over drug regulation and a reluctance by Britain's health service to use certain pricey modern medicines pose a threat to the country's respected life sciences sector, the head Swiss drugmaker Roche said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - September 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

CorFlow raises $9.7 million to launch clinical trial in Europe
Swiss medical device developer CorFlow Therapeutics said today that it has raised $9.7 million in the second close of its seed+ financing round. The first round closed in October 2017 at $2.7 million (CHF 2.6 million). The proceeds will finance the first-in-man clinical trial in Europe of the company’s controlled flow infusion (CoFITM) system, which will be studied in 40 acute heart attack patients. CorFlow said it has applied to conduct the trial in six leading cardiovascular centers in Switzerland, the U.K., Belgium and Germany. Get the full story at our sister site, Medical Design & Outsourcing. The post CorFl...
Source: Mass Device - September 12, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Funding Roundup corflowtherapeutics Source Type: news

Alcon shifting global HQ from Fort Worth to Geneva
Alcon, one of Fort Worth's biggest companies, is shifting its global headquarters to Geneva, Switzerland, after completion of the eye products firm ’s spinoff from parent company Novartis, the companies announced today. Alcon’s Fort Worth location, which is now its global divisional headquarters, will remain a “major operational, commercial and innovation hub,” according to a news release from the parent company. Alcon was founded in Fort Worth more than 70 years ago.Novartis, which is based… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 11, 2018 Category: American Health Authors: Bill Hethcock Source Type: news

Cochrane Switzerland seeks Coordinator - Lausanne, Switzerland
The Institute of Social and Preventive Medicine (IUMSP), University Hospital of Lausanne (CHUV) and the Faculty of Biology and Medicine, University of Lausanne (UNIL) offers a position of  Coordinator, Cochrane Switzerland, 50%Description:Cochrane (www.cochrane.org) is an international independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research accessible for those who need to make decisions about health.  Cochrane is a not-for-profit organisation with about 11 ’000 members and 35’...
Source: Cochrane News and Events - September 11, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Youth Soccer Injury Prevention Program Saves Healthcare Costs Youth Soccer Injury Prevention Program Saves Healthcare Costs
An injury prevention program tailored to children's soccer is not only more effective than typical warmups and stretches at keeping players safe, it's also associated with lower healthcare costs, a Swiss study suggests.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2018 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
Alcon, the global leader in eye care and a division of Novartis, today announced plans to locate its future global headquarters in the Canton of Geneva, Switzerland, following completion of its proposed spinoff from Novartis. Alcon's new global headquarters in Geneva will be the primary location for Alcon's senior corporate leadership and other corporate and commercial functions. (Source: World Pharma News)
Source: World Pharma News - September 11, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

New colour-generation mechanism discovered in 'rainbow' weevil
(Yale-NUS College) Researchers from Yale-NUS College and the University of Fribourg in Switzerland have discovered a novel color-generation mechanism in nature, which if harnessed, has the potential to create cosmetics and paints with purer and more vivid hues, screen displays that project the same true image when viewed from any angle, and even reduce the signal loss in optical fibers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 11, 2018 Category: Biology Source Type: news

Children rights charity wins $1 million humanitarian prize
An international children rights charity based in Switzerland has been awarded the 2018 Balzan Prize for humanitarian achievement (Source: ABC News: Health)
Source: ABC News: Health - September 10, 2018 Category: Consumer Health News Tags: Health Source Type: news

Four 2018 Balzan Prizewinners announced today in Milan together with their 'Peace' prize
(Gold Communications) 750,000 Swiss Francs ( € 670,000; $ 770,000) for each of the four annual subjects. Half of the amount must be destined by the winners to research projects1,000,000 Swiss Francs ( € 890,000; $ 1,000,000) for the " Peace " Prize (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 10, 2018 Category: International Medicine & Public Health Source Type: news

Youth soccer injury prevention program saves healthcare costs
(Reuters Health) - An injury prevention program tailored to children's soccer is not only more effective than typical warmups and stretches at keeping players safe, it's also associated with lower healthcare costs, a Swiss study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Swiss Advanced Vision launches Harmonis customizable IOL
Swiss Advanced Vision said yesterday it launched its Harmonis customizable intraocular lens system designed for cataract surgery. The newly launched system features advanced extended depth of focus optical technology, the Neuchatel, Switzerland-based company said, and a web-based configurator ophthalmologists can use prior to surgery to select optimal lens parameters. The web-based configurator offers selectable parameters for light ditribution ratios of near, intermediate and distance vision, reading distance and extended depth of focus, Swiss Advanced Vision said. “By expanding our product portfolio with the launch...
Source: Mass Device - September 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Swiss Advanced Vision Source Type: news

Medtronic Is an Example of Why Diversity Matters
Diversity does matter to medtech (we hope), but a recently published list suggests that some companies are doing a better job than others of making diversity and inclusion more than just a box-ticking exercise. In the medical device and diagnostics industry, Medtronic appears to be way ahead of its pure-play medtech peers on this front. Medtronic ranked third on Thomson Reuters' 2018 Diversity and Inclusion (D&L) Index, jumping ten spots from number 13, which it held in 2016 and 2017 (the D&I Index is in its third year). "We know that greater diversity inherently drives better decisions...
Source: MDDI - September 7, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

PathMaker Neurosystems Launches European Clinical Trial
PathMaker Neurosystems, a clinical stage company in the bioelectronic medicine space, is seeking to change the treatment paradigm of patients suffering from spasticity secondary to stroke with the MyoRegulator device. The company, which has a presence in both Boston and Paris, has initiated the first patient in its European clinical trial for the MyoRegulator. In addition, MyoRegulator is in clinical trials in the U.S. “We expect to have our first regulatory clearance in less than two years,” Dr. Nader Yaghoubi, president and CEO of PathMaker Neurosystems, told MD+DI. “...
Source: MDDI - September 6, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo
New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd for up to $1 billion. (Source: Reuters: Health)
Source: Reuters: Health - September 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis offloads part of generics business in US
Swiss group in drive to focus on higher-margin innovative drugs (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 6, 2018 Category: Pharmaceuticals Source Type: news

Getinge slips Abiomed counter-claim in patent spat with Maquet subsidiary
Getinge (PINK:GETI B) yesterday slipped out of a counter-suit filed by Abiomed (NSDQ:ABMD) against its Maquet subsidiary in an infringement spat over a blood pump patent. Danvers, Mass.-based Abiomed initially sued Maquet in May 2016, asking Judge Dennis Saylor of the U.S. District Court for Massachusetts for a judgment of non-infringement of a trio of patents; counter-suits later brought the number of disputed patents to six. While that case was proceeding, another Maquet patent issued – U.S. patent No. 9,789,238 covering a “guidable intravascular blood pump and related methods” ...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Legal News Abiomed Getinge Maquet Cardiovascular LLC Source Type: news

Don ’t Eat Any Honey Smacks Cereal, CDC Warns As Salmonella Outbreak Continues
Federal health officials are warning consumers to stay away from all Honey Smacks cereal, which is likely behind a multi-state salmonella outbreak that has sickened 130 people. Kellogg’s voluntarily recalled Honey Smacks in June, citing possible salmonella contamination. But the Centers for Disease Control and Prevention (CDC) announced on Tuesday that at least 30 people from 19 states have become ill since mid-July, suggesting that contaminated products may still be in people’s homes or on store shelves. “Do not eat any Kellogg’s Honey Smacks cereal, regardless of the package size or best-by date,&...
Source: TIME: Health - September 5, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Recalls Source Type: news

UK deal makes Novartis cancer cell therapy available to kids
Health authorities in England have agreed with Swiss drugmaker Novartis to fast-track access to its expensive CAR-T cell therapy Kymriah and make it available to children and young people with aggressive leukemia when other drugs have failed. (Source: Reuters: Health)
Source: Reuters: Health - September 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: How gut bacteria may help you diet and stay healthy
In a new study on mice, Swiss researchers show how gut bacteria influence the immune system, with implications for health and weight loss. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 4, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Babies conceived via IVF are SIX TIMES more likely to have high blood pressure as teenagers
Researchers from University Hospital in Bern, Switzerland, found signs of 'premature vascular aging' in children as young as 11 who had been conceived as a result of fertility treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - September 3, 2018 Category: Consumer Health News Source Type: news

Children born through IVF may have higher risk of hypertension
(American College of Cardiology) Children conceived through assisted reproductive technologies may be at an increased risk of developing arterial hypertension early in life, among other cardiovascular complications, according to a Swiss study published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 3, 2018 Category: International Medicine & Public Health Source Type: news